CK Life Sciences Int'l., (Holdings) Inc. (CK Life) is a Hong Kong-based investment holding company. The company is a member of the Cheung Kong Group. CK Life Sciences operates in Asia Pacific and North America. The company operates through three segments: agriculture-related, health and investment. CK Life Sciences' agriculture related segment is engaged in agriculture-related businesses. It has operations in Australia and Mainland China. The company operates agriculture-related businesses through vineyards, Cheetham salt, Amgrow, Accensi and China agriculture business division. The company's agriculture related segment operates through two vineyard portfolios, Belvinos portfolio and other vineyards. Its Belvinos portfolio includes 13 vineyards and other vineyards include Australia's Qualco West Vineyard and three vineyards in Margaret River, as well as New Zealand's Northbank Millennium Vineyard and Mud House Vineyards. CK Life Sciences' Cheetham salt division produces and is a refiner of salt for the domestic market. It operates six salt fields and four refineries in Australia, as well as a salt refinery in Indonesia. This salt is used in chlor-alkali, as an ingredient for food manufacturers, as an ingredient in the manufacture of stockfeed; for swimming pool sanitization; and curing of hide and skins. The company's Amgrow supplies division is engaged in home gardening, turf management, pest management as well as horticulture and broad acre businesses. The key markets are recreational turf, amenity horticulture, production horticulture, agriculture, home garden and pest management. CK Life Sciences' Accensi division is an independent toll manufacturer of crop protection products in Australia. Accensi produces emulsifiable concentrates, suspension concentrates, aqueous solutions, coated granules and powders, and offers all liquid crop protection products. It also offers additional services, including technical formulation development, storage and distribution. The company's China agriculture business division focuses on developing crop-friendly eco-fertilizers. Its subsidiaries are engaged in formulating, manufacturing and marketing input solutions that allow farmers to reduce traditional chemical fertilizer usage. CK Life Sciences' health segment focuses primarily on oncology and diseases with unmet needs. The company's pipeline products include POL-103A, a therapeutic vaccine for the treatment of melanoma and tetrodotoxin, an alternative to opiods for pain management. The company' nutraceuticals division develops non-medical products through its subsidiaries, including Sante Naturelle A.G. (SNAG), Vitaquest International (Vitaquest), and Lipa Pharmaceuticals (Lipa). SNAG is involved in manufacturing and marketing of natural healthcare products. Its current product range features over 150 natural health options. It offers natural source vitamins, minerals and herbal supplements. Vitaquest is a custom contract manufacturer and distributor of health supplements in the US. Its products range from tablets, capsules, powders and pouches to liquids, creams and lotions. Lipa is a contract manufacturer of complementary healthcare medicines, including health care medicines, vitamins and nutritional supplements in Australia. It also manufactures non-sterile prescription and over-the counter medicines. The company's investment segment is engaged in holding investments in financial and investment products. Geographically, CK Life classifies its operations into two regions, namely, Asia Pacific and North America. In FY2015, the company generated 62.5% of the revenue from Asia Pacific and followed by 37.5% from North America.
Scope of the Report
-- About the Company - Historical Details, Current Ownership Structure and basic overview of CK Life Sciences Int'l., Inc. in terms of revenue, net income, and operating income.
-- Financials - Details about CK Life Sciences Int'l., Inc. listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.
-- Company SWOT Analysis - Outlines CK Life Sciences Int'l., Inc.’s strengths, weaknesses, and opportunities and threats facing the company.
-- Recent Developments - Showcases CK Life Sciences Int'l., Inc.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
-- Strategic Evaluation - Provides an overview of CK Life Sciences Int'l., Inc.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.
Key Questions Answered
-- What domain does CK Life Sciences Int'l., Inc. operate and what are key points about it?
-- What is the product / service portfolio of CK Life Sciences Int'l., Inc.?
-- How has CK Life Sciences Int'l., Inc. performed financially from the 2013?
-- How does CK Life Sciences Int'l., Inc. rank among its peers in terms of revenue and market share?
-- What are CK Life Sciences Int'l., Inc. strengths and weaknesses and what opportunities and threats does it face?
-- What are CK Life Sciences Int'l., Inc.’s main growth strategies and how successful has the company been at implementing them?
-- What is the in-house technical capability of CK Life Sciences Int'l., Inc.? Where does it procure / outsource it?
Reasons to buy
-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost
-- 12 hour delivery time fulfilling your urgent requests as per your requirement
-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics
1. About the Company
1.1 History and Basic Facts
1.2 Ownership Structure and Key Executives
1.3 Head Office
1.4 Other Locations & Subsidiaries
1.5 List of Competitors
1.6 Employee Count & Distribution
2.1 Company Type (Listed / Unlisted)
2.2 Annual Statements
2.3 Key Financial Highlights
2.4 Region-wise Breakdown
3. Product / Services
4. SWOT Analysis
4.1 SWOT Overview
5. Recent Developments
5.1 Mergers & Acquisitions
5.2 Partnerships, Collaborations & Joint Ventures
5.3 New Product Launches
5.4 Business Expansion / Divestment
6. Strategic Evaluation
6.1 Corporate Strategy
6.2 Legal Issues
6.3 Analyst Outlook
7. Technology Landscape
-- 7.1.1 Industry Snapshot
-- 7.1.2 IT Spend
-- 7.1.3 Key Information Technology Trends
-- 7.2.1 IT Overview
-- 7.2.2 Key IT Technologies
-- 7.2.3 Recent IT Initiatives
-- 7.2.4 IT Outsourcing Engagements
-- 7.2.5 Key IT Management
-- 7.2.6 CIO/CTO Profile
-- About Us
-- Contact Us
Fig.1: Company Snapshot
Fig.2: Locations Listing on Map
Table.1: Ownership Structure
Table.2: List of Competitors
Table.3: Annual Statements
Table.4: Key Financial Highlights
Table.5: Region-wise Breakdown
Table.6: Product/Services Overview
Table.7: Mergers & Acquisitions
Table.8: Partnerships, Collaborations & Joint Ventures
Table.9: New Product Launches
Table.10: Business Expansion / Divestment
Table 11: IT Budgets
Table 12: Key IT Management (CIO / CTO)
Table 13: IT Deals undertaken in the past years